Review key evidence on the burden of tardive dyskinesia (TD), including its effects on quality of life, daily functioning, and social and emotional well-being.
Empty space, drag to resize
Up Next
RE-KINECT: Real-World Dyskinesia Screening Study
Join Dr. Andrew Cutler as he shares insights from the RE-KINECT study, including findings on the prevalence and impact of possible tardive dyskinesia (TD) in patients in outpatient psychiatry practices in the United States.
Faculty have been compensated by Neurocrine Biosciences, Inc.
Up Next
Differential Diagnosis of DRBA-induced Movement Disorders
Explore the clinical features and management strategies for the four most common dopamine-receptor-blocking agent (DRBA)-induced movement disorders: tardive dyskinesia, drug-induced parkinsonism, akathisia, and acute dystonia.
Your Resources on Tardive Dyskinesia and Other DIMDs
These
free educational resources are
sponsored and developed by
Neurocrine Biosciences, Inc.
Discover TD®
In this interactive application, users can differentially diagnose and develop appropriate
management plans for hypothetical, virtual patients with various movement disorders.
DIMD Course
Enroll in this free, virtual self-paced learning platform delving into various clinical aspects of the most common DRBA-induced movement disorders and earn a recognized certificate of completion.
Media Platforms
TD Dialogues® Podcast
Hear from experts in insightful conversations as they discuss the challenges of recognizing TD and share real-world strategies to effectively support patients
in managing symptoms.
This channel features educational videos designed
to further understanding of TD, including content on the proposed mechanism of disease in TD and differentiating TD from drug-induced parkinsonism.
Explore the DIMD Ecosystem Library
Want to explore our collection of DIMD educational resources on your own? Use the link below to view the full content library.
This educational
content was sponsored and developed
by Neurocrine Biosciences, Inc. This
non-CME program is intended to
provide general information about
drug-induced movement disorders and
not medical advice for any particular
patient.
